LOX and neoplasm: constructed Hb‐LOX‐DOX‐ZIF8@platelet membrane nanosystem (HLDZ@PM NPs) using nano‐ZIF‐8 as the carrier.[162] LOX adequately depleted intratumoral lactate, making tumor cells more sensitive to DOX‐induced chemotherapy.